Signaling coupled epigenomic regulation of gene expression.

Abstract:

:Inheritance of genomic information independent of the DNA sequence, the epigenetics, as well as gene transcription are profoundly shaped by serine/threonine and tyrosine signaling kinases and components of the chromatin remodeling complexes. To precisely respond to a changing external milieu, human cells efficiently translate upstream signals into post-translational modifications (PTMs) on histones and coregulators such as corepressors, coactivators, DNA-binding factors and PTM modifying enzymes. Because a protein with multiple residues for putative PTMs is expected to undergo more than one PTM in cells stimulated with growth factors, the outcome of combinational PTM codes on histones and coregulators is profoundly shaped by regulatory interplays between PTMs. The genomic functions of signaling kinases in cancer cells are manifested by the downstream effectors of cytoplasmic signaling cascades as well as translocation of the cytoplasmic signaling kinases to the nucleus. Signaling-mediated phosphorylation of histones serves as a regulatory switch for other PTMs, and connects chromatin remodeling complexes into gene transcription and gene activity. Here, we will discuss the recent advances in signaling-dependent epigenomic regulation of gene transcription using a few representative cancer-relevant serine/threonine and tyrosine kinases and their interplay with chromatin remodeling factors in cancer cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Kumar R,Deivendran S,Santhoshkumar TR,Pillai MR

doi

10.1038/onc.2017.201

subject

Has Abstract

pub_date

2017-10-26 00:00:00

pages

5917-5926

issue

43

eissn

0950-9232

issn

1476-5594

pii

onc2017201

journal_volume

36

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A.

    abstract::A yeast two-hybrid screen has identified HBP1 as a transcription factor capable of interacting with the pocket protein family. We show that HBP1 can interact with one of these, RB, both in vitro and in mammalian cells. Two distinct RB binding sites are present within HBP1--a high affinity binding site, mediated by an ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201243

    authors: Lavender P,Vandel L,Bannister AJ,Kouzarides T

    更新日期:1997-06-05 00:00:00

  • Future prospects for oncolytic therapy.

    abstract::Viruses have been engineered to replicate selectively in cancer cells, based on a number of innovative principles. Several of these viruses have entered clinical trials and have proven relatively safe, and have shown evidence of efficacy. However, further research is required to enable these agents to function systemi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209064

    authors: McCormick F

    更新日期:2005-11-21 00:00:00

  • The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

    abstract::Beta-transducin repeats-containing proteins (beta-TrCP) serve as the substrate recognition subunits for the SCFbeta-TrCP E3 ubiquitin ligases. These ligases ubiquitinate specifically phosphorylated substrates and play a pivotal role in the regulation of cell division and various signal transduction pathways, which, in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207389

    authors: Fuchs SY,Spiegelman VS,Kumar KG

    更新日期:2004-03-15 00:00:00

  • V-erbA generates ribosomes devoid of RPL11 and regulates translational activity in avian erythroid progenitors.

    abstract::The v-erbA oncogene transforms chicken erythrocytic progenitors (T2EC) by blocking their differentiation and freezing them in a state of self-renewal. Transcriptomes of T2EC, expressing either v-erbA or a non-transforming form of v-erbA (S61G), were compared using serial analysis of gene expression and some, but not a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.93

    authors: Nguyen-Lefebvre AT,Leprun G,Morin V,Viñuelas J,Couté Y,Madjar JJ,Gandrillon O,Gonin-Giraud S

    更新日期:2014-03-20 00:00:00

  • p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.

    abstract::The Li-Fraumeni Syndrome (LFS) is a rare, dominantly inherited syndrome that features high risk of cancers in childhood and early adulthood. Affected families tend to develop bone and soft tissue sarcomas, breast cancers, brain tumors, leukemias, and adrenocortical carcinomas. In some kindreds, the genetic abnormality...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202783

    authors: Quesnel S,Verselis S,Portwine C,Garber J,White M,Feunteun J,Malkin D,Li FP

    更新日期:1999-07-08 00:00:00

  • Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.

    abstract::Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202544

    authors: Ohtani K,Iwanaga R,Nakamura M,Ikeda M,Yabuta N,Tsuruga H,Nojima H

    更新日期:1999-04-08 00:00:00

  • Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis.

    abstract::Many components of the Wnt/β-catenin signaling pathway have critical functions in mammary gland development and tumor formation, yet the contribution of glycogen synthase kinase-3 (GSK-3α and GSK-3β) to mammopoiesis and oncogenesis is unclear. Here, we report that WAP-Cre-mediated deletion of GSK-3 in the mammary epit...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.279

    authors: Dembowy J,Adissu HA,Liu JC,Zacksenhaus E,Woodgett JR

    更新日期:2015-07-01 00:00:00

  • Cell type-specific responses of human cells to inhibition of replication licensing.

    abstract::Replication origins are 'licensed' for a single initiation event by loading Mcm2-7 complexes during late mitosis and G1. Licensing is blocked at other cell cycle stages by the activity of cyclin-dependent kinases and a small protein called geminin. Here, we describe the effects of over-expressing a non-degradable form...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205910

    authors: Shreeram S,Sparks A,Lane DP,Blow JJ

    更新日期:2002-09-26 00:00:00

  • Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma.

    abstract::Germline mutations of the RET proto-oncogene are responsible for the familial tumor syndrome called multiple endocrine neoplasia type 2 (MEN 2) that includes medullary thyroid carcinoma (MTC). Although inherited mutations of RET lead to tumor formation in patients with MEN 2, it is not understood why only selected cel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204991

    authors: Koch CA,Huang SC,Moley JF,Azumi N,Chrousos GP,Gagel RF,Zhuang Z,Pacak K,Vortmeyer AO

    更新日期:2001-11-22 00:00:00

  • PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.

    abstract::Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma upregulated factor (PAUF) has an important role in the metastasis and progression of the disease. Variations in the lev...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.298

    authors: Lee Y,Kim SJ,Park HD,Park EH,Huang SM,Jeon SB,Kim JM,Lim DS,Koh SS

    更新日期:2010-01-07 00:00:00

  • HGF-independent potentiation of EGFR action by c-Met.

    abstract::The c-Met receptor is a potential therapeutic target for non-small cell lung cancer (NSCLC). Signaling interactions between c-Met and the mutant epidermal growth factor receptor (EGFR) have been studied extensively, but signaling intermediates and biological consequences of lateral signaling to c-Met in EGFR wild-type...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.84

    authors: Dulak AM,Gubish CT,Stabile LP,Henry C,Siegfried JM

    更新日期:2011-08-18 00:00:00

  • Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor.

    abstract::A33 antigen is a membrane-bound protein that is expressed only in intestinal epithelium and in most human colon cancers. Thus, A33 antigen has been explored as a potential therapeutic target for the treatment of colon cancers. However, little is known about the mechanism responsible for the tissue-specific pattern of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206508

    authors: Mao Z,Song S,Zhu Y,Yi X,Zhang H,Shang Y,Tong T

    更新日期:2003-07-10 00:00:00

  • Different in vivo and in vitro transformation of intestinal stem cells in mismatch repair deficiency.

    abstract::Mutations in mismatch repair (MMR) genes result in microsatellite instability (MSI) and early onset of colorectal cancer. To get mechanistic insights into the time scale, sequence and frequency of intestinal stem cell (ISC) transformation, we quantified MSI and growth characteristics of organoids of Msh2-deficient and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.429

    authors: Keysselt K,Kreutzmann T,Rother K,Kerner C,Krohn K,Przybilla J,Buske P,Löffler-Wirth H,Loeffler M,Galle J,Aust G

    更新日期:2017-05-11 00:00:00

  • The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.

    abstract::Wild-type (wt) p53 acts as a tumor suppressor, while certain mutant type (mt) p53 may exhibit 'oncogenic' function. We have recently demonstrated that human papillomavirus type 18 (HPV-18) E6 can partially overcome the growth-suppressive effects of wt p53, but it remains unclear what role p53 plays in cervical carcino...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chen TM,Chen CA,Hsieh CY,Chang DY,Chen YH,Defendi V

    更新日期:1993-06-01 00:00:00

  • Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.

    abstract::Expression of neurotrophin receptors of the tyrosine kinase receptor (Trk) family is an important prognostic factor in solid tumors including neuroblastoma. High expression of TrkA (NTRK1) is associated with a favorable biology and outcome of neuroblastoma, whereas TrkB (NTRK2) is expressed on aggressive neuroblastoma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208000

    authors: Schulte JH,Schramm A,Klein-Hitpass L,Klenk M,Wessels H,Hauffa BP,Eils J,Eils R,Brodeur GM,Schweigerer L,Havers W,Eggert A

    更新日期:2005-01-06 00:00:00

  • RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation.

    abstract::The alternative nuclear factor-kappaB (NF-κB) -activation pathway proceeds via inducible p100 processing, leading to the activation of RelB-containing dimers. This pathway is aberrantly activated in several types of tumors; however, a direct role for RelB in the control of cell proliferation is still largely unexplore...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.282

    authors: Jacque E,Billot K,Authier H,Bordereaux D,Baud V

    更新日期:2013-05-23 00:00:00

  • Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells.

    abstract::Thymidine kinase (TK) is a nucleotide salvage pathway enzyme whose activity is highly dependent on the growth state and cell cycle phase of a cell. Cells in the resting or quiescent (G0) phase express very low levels of TK mRNA and protein. When quiescent cells are stimulated to enter the cell cycle by the addition of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kauffman MG,Rose PA,Kelly TJ

    更新日期:1991-08-01 00:00:00

  • Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.

    abstract::The ret proto-oncogene expresses four major mRNA species of different lengths in human malignant cell lines and rat tissues. We isolated ret proto-oncogene cDNA clones from a cDNA library of a human neuroblastoma line, Nagai, which over-expressed these mRNAs. Four cDNA clones differing from each other in their 3' port...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tahira T,Ishizaka Y,Itoh F,Sugimura T,Nagao M

    更新日期:1990-01-01 00:00:00

  • Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.

    abstract::Tumor-derived DNA from a non-Hodgkin's (T cell) lymphoma patient, assayed by NIH3T3 transfection followed by inoculation of cells into nude mice, was found to contain an activated N-ras proto-oncogene. The mode of activation was determined by hybridization with N-ras-specific oligonucleotide probes detecting mutations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wodnar-Filipowicz A,Senn HP,Jiricny J,Signer E,Moroni C

    更新日期:1987-01-01 00:00:00

  • Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

    abstract::The RAS-RAF-MEK-ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF and MEK inhibitors are available that provide survival benefits...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-018-0171-x

    authors: Dankner M,Rose AAN,Rajkumar S,Siegel PM,Watson IR

    更新日期:2018-06-01 00:00:00

  • Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.

    abstract::Transformed cells express high levels of non-telomeric reverse-transcriptase (RT) activity of retrotransposon and endogenous retrovirus origin. We previously reported that RT inhibition, either pharmacological or through transient silencing of RT-encoding LINE-1 (L1) elements by RNA interference (RNAi), reduced prolif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210214

    authors: Oricchio E,Sciamanna I,Beraldi R,Tolstonog GV,Schumann GG,Spadafora C

    更新日期:2007-06-21 00:00:00

  • p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.

    abstract::Mutations in the p53 tumour suppressor gene have been recently described in hepatocellular carcinomas (HCC) from high risk areas such as China and South Africa. Our study was designed to assess the importance of p53 aberrations in HCCs from Europe, where the major risk factors in hepatocarcinogenesis, aflatoxin exposu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Volkmann M,Hofmann WJ,Müller M,Räth U,Otto G,Zentgraf H,Galle PR

    更新日期:1994-01-01 00:00:00

  • Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.

    abstract::Inactivation of the transforming growth factor-beta (TGF-beta) pathway occurs often in malignancies of the gastrointestinal (GI) system. However, only a fraction of sporadic GI tumors exhibit inactivating mutations in early stages of cancer formation, suggesting that other mechanisms play a critical role in the inacti...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209211

    authors: Katuri V,Tang Y,Li C,Jogunoori W,Deng CX,Rashid A,Sidawy AN,Evans S,Reddy EP,Mishra B,Mishra L

    更新日期:2006-03-23 00:00:00

  • Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.

    abstract::In contrast to the hereditary form of medullary thyroid carcinoma (MTC), little is known about the etiology of sporadic MTC. Somatic gain-of-function mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, are found in an average of 40% of sporadic MTC. We analysed 31 sporadic MTC for somatic and ger...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204289

    authors: Gimm O,Dziema H,Brown J,Hoang-Vu C,Hinze R,Dralle H,Mulligan LM,Eng C

    更新日期:2001-04-19 00:00:00

  • Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.

    abstract::Fatty acid binding protein 4 (FABP4) is a fatty acid chaperone, which is induced during adipocyte differentiation. Previously we have shown that FABP4 in endothelial cells is induced by the NOTCH1 signalling pathway, the latter of which is involved in mechanisms of resistance to antiangiogenic tumour therapy. Here, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.256

    authors: Harjes U,Bridges E,Gharpure KM,Roxanis I,Sheldon H,Miranda F,Mangala LS,Pradeep S,Lopez-Berestein G,Ahmed A,Fielding B,Sood AK,Harris AL

    更新日期:2017-02-16 00:00:00

  • KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model.

    abstract::Krüppel-like transcription factor 10 (KLF10), also named as TIEG1, plays essential roles in mediating transforming growth factor beta (TGFβ) signaling and has been shown to function as a tumor suppressor in multiple cancer types. However, its roles in mediating cancer progression in vivo have yet to be fully character...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.155

    authors: Weng CC,Hawse JR,Subramaniam M,Chang VHS,Yu WCY,Hung WC,Chen LT,Cheng KH

    更新日期:2017-09-28 00:00:00

  • BMP6-induced modulation of the tumor micro-milieu.

    abstract::Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progressi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0475-x

    authors: Stieglitz D,Lamm S,Braig S,Feuerer L,Kuphal S,Dietrich P,Arndt S,Echtenacher B,Hellerbrand C,Karrer S,Bosserhoff AK

    更新日期:2019-01-01 00:00:00

  • Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.

    abstract::We have characterized a chromosomal translocation in a cell line (SU-DUL5) established from a patient with lymphoblastic lymphoma in which the c-myc gene on chromosome 8 was juxtaposed to a t(14;18). Cytogenetic analysis of this cell line showed 14q+, 18q-, and 8p+q+ marker chromosomes in the absence of t(14;18). Geno...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kiem HP,Nourse J,Saltman DL,Blume KG,Cleary ML

    更新日期:1990-12-01 00:00:00

  • Endonuclein is a cell cycle regulated WD-repeat protein that is up-regulated in adenocarcinoma of the pancreas.

    abstract::The transcript encoding endonuclein, the human homolog of yeast PWP1, was previously found up-regulated in pancreatic cancer tissue. By immunohistochemistry we detected a ubiquitous presence in several tissues examined: skin, liver, thyroid gland, heart muscle, neurons, kidney, bladder, pancreas, adrenal gland, ovary,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205186

    authors: Honoré B,Baandrup U,Nielsen S,Vorum H

    更新日期:2002-02-07 00:00:00

  • Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

    abstract::Familial adenomatous polyposis (FAP) is caused by germline mutations in the adenomatous polyposis coli (APC) gene. Two promoters, 1A and 1B, have been recognized in APC, and 1B is thought to have a minor role in the regulation of the gene. We have identified a novel deletion encompassing half of this promoter in the l...

    journal_title:Oncogene

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1038/onc.2011.201

    authors: Rohlin A,Engwall Y,Fritzell K,Göransson K,Bergsten A,Einbeigi Z,Nilbert M,Karlsson P,Björk J,Nordling M

    更新日期:2011-12-15 00:00:00